Haglund Long-term outcomes in patients treated with tissue-sparing posterior cervical fusion to revise a 1-level pseudarthrosis following ACDF - Providence Medical Technology, Inc.
Request Training
CERVICAL
CORUS™ Spinal System
CORUS™ PCSS
CAVUX® ffs
CAVUX® Cervical Cages
ALLY® Screw Systems
ENTRUS® Allograft Bone
DiViNE™ Portal System
LUMBAR
CORUS™ Spinal System-LX
CAVUX® ffs-lx
CORUS™ NAVIGATION ACCESS system
For surgeons
Training
Publications
Company
About us
Board of directors
Management team
Intellectual property
News and Events
Clinical Studies
Fuse Study
Contact Us
Careers
Products
CORUS™ Spinal System
CORUS™ PCSS
CAVUX® ffs
CAVUX® Cervical Cages
ALLY® Screw Systems
CORUS™ Spinal System-LX
CAVUX® FFS-LX
CORUS™ NAVIGATION ACCESS SYSTEM
DiViNE™ Portal System
ENTRUS® Allograft Bone
For Surgeons
Training
Publications
Company
About us
Board of directors
Management team
Intellectual property
News and Events
Clinical
Fuse Study
PCSS
Contact Us
Careers
Request Training

Long-term outcomes in patients treated with tissue-sparing posterior cervical fusion to revise a 1-level pseudarthrosis following ACDF.

Haglund MM, McCormack BM, Williams DM, Lemons AC, Summerside EM. 

J Clin Neurosci. 2023 Nov 21;119:85-92. doi: 10.1016/j.jocn.2023.11.020. PMID: 37992419.
View Full Publication (PDF)
Learn more about CAVUX® FFS
Haglund MM, McCormack BM, Williams DM, Lemons AC, Summerside EM. Long-term outcomes in patients treated with tissue-sparing posterior cervical fusion to revise a 1-level pseudarthrosis following ACDF. J Clin Neurosci. 2023 Nov 21;119:85-92. doi: 10.1016/j.jocn.2023.11.020. Epub ahead of print. PMID: 37992419.

Abstract

Background: Symptomatic pseudarthrosis is one long-term complication in patients treated with anterior discectomy and fusion (ACDF). When revising a pseudarthrosis, a surgeon must decide to intervene posteriorly and/or anteriorly. Open posterior cervical fusion (PCF) is attractive for high rates of arthrodesis, however this technique introduces risks of added complications resulting from extensive soft tissue dissection. The purpose of this study was to assess long-term outcomes in patients undergoing tissue-sparing PCF with facet instrumentation to treat a single-level pseudarthrosis.

Methods: Forty-five subjects were recruited from six participating sites. All subjects had a history of ACDF that was subsequently revised with tissue-sparing PCF to treat symptomatic pseudarthrosis at one level. Long-term radiographic assessments included flexion and extension X-ray and multi-planar CT. Subjects additionally completed a patient satisfaction questionnaire. Radiographs were assessed by investigators and an independent core imaging lab to diagnose implant integrity and arthrodesis at the revised levels.

Results: The revision procedure required a median 49 min to complete with an estimated blood loss of 10 cc. Subjects were discharged a median 1 day following treatment. There were no instances of hospital re-admission nor subsequent surgical interventions. Study follow-up assessments were performed a median 39 months from revision. Surgeons diagnosed complete fusion in 91 % of cases. The core imaging lab identified bridging bone across the revised segment in 80 % of cases. Range of motion was < 2° in 93 % of cases. Seventy-four percent of subjects reported being satisfied with their outcomes. Conclusions This study summarizes long-term radiographic outcomes in a cohort of patients receiving tissue-sparing PCF for the treatment of pseudarthrosis. Assessed years after revision, patients achieved rates of arthrodesis similar to open PCF without the soft tissue dissection responsible for perioperative morbidity and long-term soft tissue pain.

Study Design: Observational Study

Author keywords: Cervical, Pseudarthrosis, Non-union, Revision, PCF, Tissue sparing, Facet instrumentation

Haglund MM, McCormack BM, Williams DM, Lemons AC, Summerside EM. Long-term outcomes in patients treated with tissue-sparing posterior cervical fusion to revise a 1-level pseudarthrosis following ACDF. J Clin Neurosci. 2023 Nov 21;119:85-92. doi: 10.1016/j.jocn.2023.11.020. Epub ahead of print. PMID: 37992419.
Intellectual PropertyPrivacy PolicyTerms of UseContact Us
Team | Innovation | Quality | Passion | Transparency
Copyright © 2025, Providence Medical Technology. All rights reserved.
Hello,
We noticed you are visiting the Providence Medical Technology website from outside of the United States. Would you like to visit our international site?
Yes, Take Me to the International SiteNo, stay on the US site
closechevron-downbarsdot-circle-o